In the article by Smith et al, “Moving From Political Declaration to Action on Reducing the Global Burden of Cardiovascular Diseases: A Statement From the Global Cardiovascular Disease Taskforce,” which published online September 17, 2013, and appeared in the December 3/10, 2013, issue of the journal (Circulation. 2013;128:2546–2548), several corrections were needed.
On page 2548 in the Writing Group Disclosures table, several of the disclosures for David A. Wood, MSc, FRCP, FRCPE, FFPHM, FESC, were incorrect:
Under Employment, the listing read, “National Heart and Lung Institute, United Kingdom.” It has been changed to read, “Imperial College London.”
Under Research Grant, the disclosure read, “PI for EUROACTION+Study and EUROASPIRE IV survey (central coordination).†” It has been changed to read, “None.”
Under Other Research Support, the disclosure read, “EUROASPIRE IV split between: Roche, MSD, Bristol-Myers Squibb Emea Sarl, AstraZeneca, GlaxoSmithKline (central coordination).†” It has been changed to read, “None.”
Under Ownership Interest, the disclosure read, “Non-executive director of MyAction Ltd (Imperial College/Innovations healthcare company). 5% equity stake.†” It has been changed to read, “None.”
Under Consultant/Advisory Board, the disclosure read, “Merck*; Sharp & Dohme.*” It has been changed to read “MSD.*”
The revised section of the Writing Group Disclosures table is reproduced here.
These corrections have been made to the print version and to the current online version of the article, which is available at http://circ.ahajournals.org/content/128/23/2546.
- © 2013 American Heart Association, Inc.